CLINICAL STUDIES OF SM-4300 IN COMBINATION WITH ANTIBIOTICS AGAINST SEVERE BACTERIAL INFECTIONS

SM-4300, a newly developed human immunoglobulin preparation was evaluated in 24 patients with severe bacterial infections and the following results were obtained. 1. The clinical efficacy was excellent in 4 cases, good in 7, fair in 5, poor in 3 and unknown in 5 with the effective rate of 57.9%. 2....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1985/09/25, Vol.38(9), pp.2673-2682
Hauptverfasser:	KINOSHITA, AKIO, IZUMI, BUNJI, MURATA, ETSUO, KAWAGUCHI, HIDETOSHI, NAKAKUMA, KENICHIRO, OGATA, KENJI, YAMAZAKI, KENJI, TOGAMI, KOICHIRO, UEMURA, KUNINORI, ARASE, MASANOBU, KAKIUCHI, MASANORI, TANAKA, MICHINOBU, UCHIDA, MITSUKUNI, MOCHINAGA, MIZUHO, HAGIWARA, NAOKI, FURUSHO, NOBUYUKI, OTSUKA, NORIO, MAKI, SHOJIRO, KOSHI, SHUICHI, HIRAOKA, TAKEHISA, YAMAGUCHI, TAKUO, YAMAMOTO, TATSUYA, MATSUMURA, YASUHIRO, HASEGAWA, YOSHIHIDE, MIYAUCHI, YOSHIMASA, KIKUYA, YUSAKU, ARATAKE, YUSUKE
Format:	Artikel
Sprache:	jpn
Schlagworte:	Adolescent Adult Aged Anti-Bacterial Agents - administration & dosage Bacteria - immunology Bacterial Infections - therapy Drug Evaluation Drug Resistance, Microbial Drug Therapy, Combination Female Humans Immunization, Passive Immunoglobulins - administration & dosage Male Middle Aged Postoperative Complications - therapy Surgical Wound Infection - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	SM-4300, a newly developed human immunoglobulin preparation was evaluated in 24 patients with severe bacterial infections and the following results were obtained. 1. The clinical efficacy was excellent in 4 cases, good in 7, fair in 5, poor in 3 and unknown in 5 with the effective rate of 57.9%. 2. No serious side effect nor abnormalities in laboratory findings due to administration of SM-4300 were observed except 1 case with slight elevation of GOT and GPT.
ISSN:	0368-2781 2186-5477
DOI:	10.11553/antibiotics1968b.38.2673